Literature DB >> 23044748

Association of body mass index and risk of death from pancreas cancer in Asians: findings from the Asia Cohort Consortium.

Yingsong Lin1, Rong Fu, Eric Grant, Yu Chen, Jung Eun Lee, Prakash C Gupta, Kunnambath Ramadas, Manami Inoue, Shoichiro Tsugane, Yu-Tang Gao, Akiko Tamakoshi, Xiao-Ou Shu, Kotaro Ozasa, Ichiro Tsuji, Masako Kakizaki, Hideo Tanaka, Chien-Jen Chen, Keun-Young Yoo, Yoon-Ok Ahn, Habibul Ahsan, Mangesh S Pednekar, Catherine Sauvaget, Shizuka Sasazuki, Gong Yang, Yong-Bing Xiang, Waka Ohishi, Takashi Watanabe, Yoshikazu Nishino, Keitaro Matsuo, San-Lin You, Sue K Park, Dong-Hyun Kim, Faruque Parvez, Betsy Rolland, Dale McLerran, Rashmi Sinha, Paolo Boffetta, Wei Zheng, Mark Thornquist, Ziding Feng, Daehee Kang, John D Potter.   

Abstract

We aimed to examine the association between BMI and the risk of death from pancreas cancer in a pooled analysis of data from the Asia Cohort Consortium. The data for this pooled analysis included 883 529 men and women from 16 cohort studies in Asian countries. Cox proportional-hazards models were used to estimate the hazard ratios and 95% confidence intervals for pancreas cancer mortality in relation to BMI. Seven predefined BMI categories (<18.5, 18.5-19.9, 20.0-22.4, 22.5-24.9, 25.0-27.4, 27.5-29.9, ≥ 30) were used in the analysis, with BMI of 22.5-24.9 serving as the reference group. The multivariable analyses were adjusted for known risk factors, including age, smoking, and a history of diabetes. We found no statistically significant overall association between each BMI category and the risk of death from pancreas cancer in all Asians, and obesity was unrelated to the risk of mortality in both East Asians and South Asians. Age, smoking, and a history of diabetes did not modify the association between BMI and the risk of death from pancreas cancer. In planned subgroup analyses among East Asians, an increased risk of death from pancreas cancer among those with a BMI less than 18.5 was observed for individuals with a history of diabetes; hazard ratio=2.01 (95% confidence interval: 1.01-4.00) (P for interaction=0.07). The data do not support an association between BMI and the risk of death from pancreas cancer in these Asian populations.

Entities:  

Mesh:

Year:  2013        PMID: 23044748      PMCID: PMC3838869          DOI: 10.1097/CEJ.0b013e3283592cef

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  36 in total

1.  Body mass index and mortality in China: a 15-year prospective study of 220 000 men.

Authors:  Zhengming Chen; Gonghuan Yang; Alison Offer; Maigeng Zhou; Margaret Smith; Richard Peto; Hui Ge; Ling Yang; Gary Whitlock
Journal:  Int J Epidemiol       Date:  2012-01-31       Impact factor: 7.196

Review 2.  Molecular mechanisms of cancer development in obesity.

Authors:  Melin J Khandekar; Paul Cohen; Bruce M Spiegelman
Journal:  Nat Rev Cancer       Date:  2011-11-24       Impact factor: 60.716

3.  Coordinating centers in cancer epidemiology research: the Asia Cohort Consortium coordinating center.

Authors:  Betsy Rolland; Briana R Smith; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-29       Impact factor: 4.254

Review 4.  Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies.

Authors:  Qiwen Ben; Maojin Xu; Xiaoyan Ning; Jun Liu; Shangyou Hong; Wen Huang; Huagao Zhang; Zhaoshen Li
Journal:  Eur J Cancer       Date:  2011-03-31       Impact factor: 9.162

5.  Body-mass index and mortality in Korean men and women.

Authors:  Sun Ha Jee; Jae Woong Sull; Jungyong Park; Sang-Yi Lee; Heechoul Ohrr; Eliseo Guallar; Jonathan M Samet
Journal:  N Engl J Med       Date:  2006-08-22       Impact factor: 91.245

6.  Abnormal glucose metabolism and pancreatic cancer mortality.

Authors:  S M Gapstur; P H Gann; W Lowe; K Liu; L Colangelo; A Dyer
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

Review 7.  Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies.

Authors:  D Aune; D C Greenwood; D S M Chan; R Vieira; A R Vieira; D A Navarro Rosenblatt; J E Cade; V J Burley; T Norat
Journal:  Ann Oncol       Date:  2011-09-02       Impact factor: 32.976

8.  Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition.

Authors:  Amy Berrington de González; Elizabeth A Spencer; H Bas Bueno-de-Mesquita; Andrew Roddam; Rachel Stolzenberg-Solomon; Jytte Halkjaer; Anne Tjønneland; Kim Overvad; Francoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Heiner Boeing; Tobias Pischon; Jakob Linseisen; Sabine Rohrmann; Antonia Trichopoulou; Vassiliki Benetou; Aristoteles Papadimitriou; Valeria Pala; Domenico Palli; Salvatore Panico; Rosario Tumino; Paolo Vineis; Hendriek C Boshuizen; Marga C Ocke; Petra H Peeters; Eiliv Lund; Carlos A Gonzalez; Nerea Larrañaga; Carmen Martinez-Garcia; Michelle Mendez; Carmen Navarro; J Ramón Quirós; María-José Tormo; Göran Hallmans; Weimin Ye; Sheila A Bingham; Kay-Tee Khaw; Naomi Allen; Tim J Key; Mazda Jenab; Teresa Norat; Pietro Ferrari; Elio Riboli
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-05       Impact factor: 4.254

9.  Meta-analysis identifies common variants associated with body mass index in east Asians.

Authors:  Wanqing Wen; Yoon-Shin Cho; Wei Zheng; Rajkumar Dorajoo; Norihiro Kato; Lu Qi; Chien-Hsiun Chen; Ryan J Delahanty; Yukinori Okada; Yasuharu Tabara; Dongfeng Gu; Dingliang Zhu; Christopher A Haiman; Zengnan Mo; Yu-Tang Gao; Seang-Mei Saw; Min-Jin Go; Fumihiko Takeuchi; Li-Ching Chang; Yoshihiro Kokubo; Jun Liang; Mei Hao; Loïc Le Marchand; Yi Zhang; Yanling Hu; Tien-Yin Wong; Jirong Long; Bok-Ghee Han; Michiaki Kubo; Ken Yamamoto; Mei-Hsin Su; Tetsuro Miki; Brian E Henderson; Huaidong Song; Aihua Tan; Jiang He; Daniel P-K Ng; Qiuyin Cai; Tatsuhiko Tsunoda; Fuu-Jen Tsai; Naoharu Iwai; Gary K Chen; Jiajun Shi; Jianfeng Xu; Xueling Sim; Yong-Bing Xiang; Shiro Maeda; Rick T H Ong; Chun Li; Yusuke Nakamura; Tin Aung; Naoyuki Kamatani; Jian-Jun Liu; Wei Lu; Mitsuhiro Yokota; Mark Seielstad; Cathy S J Fann; Jer-Yuarn Wu; Jong-Young Lee; Frank B Hu; Toshihiro Tanaka; E Shyong Tai; Xiao-Ou Shu
Journal:  Nat Genet       Date:  2012-02-19       Impact factor: 38.330

10.  Body mass index and mortality from all causes and major causes in Japanese: results of a pooled analysis of 7 large-scale cohort studies.

Authors:  Shizuka Sasazuki; Manami Inoue; Ichiro Tsuji; Yumi Sugawara; Akiko Tamakoshi; Keitaro Matsuo; Kenji Wakai; Chisato Nagata; Keitaro Tanaka; Tetsuya Mizoue; Shoichiro Tsugane
Journal:  J Epidemiol       Date:  2011-09-10       Impact factor: 3.211

View more
  14 in total

Review 1.  Toward Rigorous Data Harmonization in Cancer Epidemiology Research: One Approach.

Authors:  Betsy Rolland; Suzanna Reid; Deanna Stelling; Greg Warnick; Mark Thornquist; Ziding Feng; John D Potter
Journal:  Am J Epidemiol       Date:  2015-11-20       Impact factor: 4.897

Review 2.  Prognostic factors related with survival in patients with pancreatic adenocarcinoma.

Authors:  Ahmet Bilici
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 3.  Premorbid Obesity and Mortality in Patients With Pancreatic Cancer: A Systematic Review and Meta-analysis.

Authors:  Kaustav Majumder; Arjun Gupta; Nivedita Arora; Preet Paul Singh; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2015-10-14       Impact factor: 11.382

4.  Statins and pancreatic cancer.

Authors:  Jun Gong; Esha Sachdev; Lori A Robbins; Emily Lin; Andrew E Hendifar; Monica M Mita
Journal:  Oncol Lett       Date:  2017-01-04       Impact factor: 2.967

Review 5.  Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery.

Authors:  Shuhei Shinoda; Naohiko Nakamura; Brett Roach; David A Bernlohr; Sayeed Ikramuddin; Masato Yamamoto
Journal:  Biomedicines       Date:  2022-05-31

6.  Lifestyle, body mass index, diabetes, and the risk of pancreatic cancer in a nationwide population-based cohort study with 7.4 million Korean subjects.

Authors:  Byung Kyu Park; Jeong Hun Seo; Jae Bock Chung; Jung Kyu Choi
Journal:  Br J Cancer       Date:  2022-04-20       Impact factor: 9.075

7.  The impact of low body mass index on postoperative outcomes in pancreatectomy patients: a retrospective analysis of Japanese administrative data.

Authors:  Takeshi Umegaki; Susumu Kunisawa; Masaya Kotsuka; So Yamaki; Takahiko Kamibayashi; Yuichi Imanaka
Journal:  J Anesth       Date:  2018-06-23       Impact factor: 2.078

8.  Detection of TP53 R249 Mutation in Iranian Patients with Pancreatic Cancer.

Authors:  Ashraf Mohamadkhani; Elnaz Naderi; Maryam Sharafkhah; Hamid Reza Fazli; Malihe Moradzadeh; Akram Pourshams
Journal:  J Oncol       Date:  2013-12-30       Impact factor: 4.375

9.  Body mass index and risk of pancreatic cancer in a Chinese population.

Authors:  Seema Untawale; Andrew O Odegaard; Woon-Puay Koh; Ai Zhen Jin; Jian-Min Yuan; Kristin E Anderson
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

10.  Racial/ethnic disparities in weight or BMI change in adulthood and pancreatic cancer incidence: The multiethnic cohort.

Authors:  Albert J Farias; Samantha A Streicher; Daniel O Stram; Songren Wang; Stephen J Pandol; Loïic Le Marchand; Veronica W Setiawan
Journal:  Cancer Med       Date:  2021-05-16       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.